David B. Smith

David B. Smith is currently the EVP, Head of Chemical Operations at Aligos Therapeutics. David has also been a Vice President, Global Research and Development Leader, Hepatology for both The Janssen Pharmaceutical Companies of Johnson & Johnson and Alios BioPharma. David has also been a Principal Research Scientist at Roche Palo Alto and a Research Scientist at Syntex. In addition to their research, David has also taught as a Consulting Associate Professor of Chemistry at Stanford University.

David B. Smith completed their undergraduate studies at the University of California, Berkeley, where they earned a B.S. in Chemistry. David then went on to complete their Ph.D. at Harvard University in Chemistry. After finishing their Ph.D., they did a post-doc at Stanford University in Chemistry. Finally, they completed their M.S. and M.Phil. at Yale University in Chemistry.

David B. Smith works with John Fry - EVP, Clinical Development, Leonid Beigelman - President and Director, and Lesley Ann Calhoun - EVP, CFO. David B. Smith reports to Lawrence M. Blatt, Chief Executive Officer and Director.